In vivo manipulation of dendritic cells to induce therapeutic immunity

Blood

Volumn 99, Issue 5, 2002, Pages 1676-1682

  Merad, Miriam ^a   Sugie, Tomoharu ^a   Engleman, Edgar G ^a,b   Fong, Lawrence ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford California and Cofounder   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FLT3 LIGAND; GROWTH FACTOR; IMMUNOSTIMULATING AGENT; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HELPER CELL; IMMUNOMODULATION; IMMUNOTHERAPY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY;

EID: 0036493558     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.5.1676     Document Type: Article

References (36)

1. Immunobiology of dendritic cells
2. Dendritic cells and the control of immunity
3. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells
4. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
5. Human renal-cell carcinoma tissue contains dendritic cells
6. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: Role of interleukin-6 and macrophage colony-stimulating factor
7. Decreased antigen presentation by dendritic cells in patients with breast cancer
8. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
9. + T cell adoptive immunotherapy
10. Paracrine cytokine adjuvants in cancer immunotherapy
11. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
12. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
13. Dendritic cells in cancer immunotherapy
14. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
15. A Toll-like receptor recognizes bacterial DNA
16. T cell receptor antagonist peptides induce positive selection
17. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
18. Introduction of soluble protein into the class I pathway of antigen processing and presentation
19. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
20. Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo
21. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
22. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
23. Flt3 ligand induces tumor regression and antitumor immune responses in vivo
24. Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant
25. CpG motifs induce Langerhans cell migration in vivo
26. Bacterial CpG DNA activates immune cells to signal infectious danger
27. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12
28. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
29. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins
30. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism
31. + T-helper and a T-killer cell
32. Help for cytotoxic-T-cell responses is mediated by CD40 signaling
33. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: Implications for anti-cancer and antiviral therapy
34. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
35. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
36. CpG motifs in bacterial DNA trigger direct B-cell activation